Traditional Chinese medicine composition for treating triple negative breast cancer and traditional Chinese medicine preparation and application thereof
The invention provides a traditional Chinese medicine composition for treating triple negative breast cancer and a traditional Chinese medicine preparation and application thereof. The traditional Chinese medicine composition comprises codonopsis pilosula, bighead atractylodes rhizome, processed rhizoma arisaematis, fructus gardeniae praeparatus, fermented soybean, thunberg fritillary bulb, bulbus fritillariae cirrhosae, platycodon grandiflorum, ligusticum wallichii, tangerine leaves, silkworm larva, gecko, radix ranunculi ternati, schisandra chinensis and raw liquorice. The traditional Chinese medicine composition is subjected to traditional Chinese medicine formula screening according to the theory of traditional Chinese medicine and the theory of treatment based on syndrome differentiation, is rigorous in formula, has the effects of inhibiting tumor cell proliferation, reducing toxicity, improving efficacy and relieving discomfort of patients aiming at triple-negative breast cancer patients with the syndrome of deficiency of vital qi and exuberant toxicity based on traditional Chinese medicine differentiation, and can consolidate basis and strengthen primordial qi in the consolidation treatment stage after operation or radiotherapy and chemotherapy. Relapse and metastasis are prevented, the patient lifetime is prolonged, and the patient life quality is improved..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 11. Juli Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LU WENPING [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-07-11, Last update posted on www.tib.eu: 2023-11-28, Last updated: 2023-12-01 |
|---|
| Patentnummer: |
CN116407595 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018151612 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018151612 | ||
| 003 | DE-627 | ||
| 005 | 20231201100018.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231013s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018151612 | ||
| 035 | |a (EPA)CN116407595 | ||
| 035 | |a (EPA)87059449 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LU WENPING |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Traditional Chinese medicine composition for treating triple negative breast cancer and traditional Chinese medicine preparation and application thereof |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-07-11, Last update posted on www.tib.eu: 2023-11-28, Last updated: 2023-12-01 | ||
| 520 | |a The invention provides a traditional Chinese medicine composition for treating triple negative breast cancer and a traditional Chinese medicine preparation and application thereof. The traditional Chinese medicine composition comprises codonopsis pilosula, bighead atractylodes rhizome, processed rhizoma arisaematis, fructus gardeniae praeparatus, fermented soybean, thunberg fritillary bulb, bulbus fritillariae cirrhosae, platycodon grandiflorum, ligusticum wallichii, tangerine leaves, silkworm larva, gecko, radix ranunculi ternati, schisandra chinensis and raw liquorice. The traditional Chinese medicine composition is subjected to traditional Chinese medicine formula screening according to the theory of traditional Chinese medicine and the theory of treatment based on syndrome differentiation, is rigorous in formula, has the effects of inhibiting tumor cell proliferation, reducing toxicity, improving efficacy and relieving discomfort of patients aiming at triple-negative breast cancer patients with the syndrome of deficiency of vital qi and exuberant toxicity based on traditional Chinese medicine differentiation, and can consolidate basis and strengthen primordial qi in the consolidation treatment stage after operation or radiotherapy and chemotherapy. Relapse and metastasis are prevented, the patient lifetime is prolonged, and the patient life quality is improved. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHANG MENGFAN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 11. Juli |
| 773 | 1 | 8 | |g year:2023 |g day:11 |g month:07 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/87059449/publication/CN116407595A1?q=CN116407595 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 11 |c 07 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 11 |c 07 | ||